Breast Cancer Screening Market Global Forecast by Screening Tests

1. Breast Cancer Screening Market Breast Cancer Screening Market

2. Report Description and Highlights Globally, breast cancer is considered one of the most common cancers in women around the world. Breast cancer is also a leading cause of death from cancer in the world's least developed nations. Every year 1.7 Million new cases are diagnosed with breast cancer, and approximately 60% of deaths due to breast cancer occur around the world. Breast cancer is a form of cancer that occurs in the tissue of the breast. Formations of a lump in a breast and red patches on the skin are some of the typical breast cancer signs. Obesity, lack of physical activity, overexposure to radiation, and consuming alcohol are among the risk factors for breast cancer growth. According to Renub Research report, the Global Breast Cancer Screening Market is anticipated to reach US$ 51.8 Billion by the end of the year 2026, with double-digitCAGR during the forecast period. Breast Cancer Screening Market

3. Breast Cancer Screening Market COVID – 19 impact on Breast Cancer Screening Market Worldwide The COVID-19 outbreak could have an impact on all drug companies manufacturing, supply chain, and clinical trial operations. In the year 2020, the global breast cancer screening population, as well as the market, will decline. The primary reason for this decline is a coronavirus. For a complete analysis, read our report as to how COVID – 19 is affecting every quarter of the year 2020 and when the market will revive? Other challenges of breast cancer screening are high medication costs, therapy-related adverse effects, and lengthy product approval times are responsible for curbing market growth. Growth Factors for Global Breast Cancer Screening Market  The key growth factors of the breast cancer market are the increasing number of females suffering from breast cancer, growing older women population is the primary factor for the growth of the market. In addition to this adoption of an unhealthy lifestyle, the rise of the female geriatric population, exposure to harmful radiation, and increased policy measures have contributed to market growth. Breast Cancer Screening Market

4. Breast Cancer Screening Market Also, the incidence of breast cancer is rising in the lower-income countries due to an increase in life expectancy, adaption to increasing urbanization and western lifestyles. World over, more than half of the breast cancer cases now have been reported from low and middle-income countries (LMICs) as these countries do not have proper breast screening programs; hence, the majority of cases are diagnosed in late stages. Growing breast cancer incidences & mortality in the low and middle-income countries, these countries need to develop an effective breast cancer screening program strategy that will address the earlier deduction of incidence of breast cancer for women. Some of the major breast cancer screening technologies which help to find breast cancer after diagnosis are as follows. Breast cancer screening technologies are MRI, Ultrasound, and mammography screening. Mammography screening aims at minimizing the death rate from breast cancer by identifying unsuspected breast cancers early. The breast cancer mammography screening market is flourishing, driven by advances in technologies and delivery models, product innovations, increasing use of digital mammography equipment, and growing public awareness. Globally, awareness about breast cancer is increasing, with more women coming forward for their yearly mammograms after the age of 40 years. Breast Cancer Screening Market

5. Breast Cancer Screening Market Besides, around the world, governments have introduced screening programs for early detection that entails a routine check-up. Several countries are already offering breast cancer screening programs for women, and the number is establishing these programs are steadily increasing. In Germany, for example, the “Mammo Screening” program exists since 2002. In the United States, most states are introducing laws requiring health insurance companies to reimburse all or part of the cost of screening mammograms. Furthermore, the NHS Breast Screening Program in the United Kingdom provides free breast screening every three years for all women aged. Also, continuous efforts are taken by various government agencies and NGOs, the worldwide market for breast cancer screening. Request a free sample copy of the report:https://www.renub.com/request-sample-page.php?gturl=breast-cancer-screening-mammography-mri-and-ultrasound-market-and-forecast-worldwide-63-p.php Breast Cancer Screening Market

6. Breast Cancer Screening Market Renub Research latest study report “Breast Cancer Screening Market, Population, By Screening Tests [Mammography, Magnetic Resonance Imaging (MRI) & Ultrasound] Countries (United States, Canada, France, United Kingdom, Germany, Italy, Spain, Netherlands, Norway, Switzerland, China, India, Korea, Japan, Singapore, Thailand, Malaysia, Brazil, Australia, New Zealand, South Africa, United Arab Emirates, Saudi Arabia), Company Analysis (AstraZeneca, Novartis, Sanofi, Pfizer, Bayer AG)” provides a detailed and comprehensive insight of the Breast Cancer Screening Market. Screening Tests - Mammography is the Most Common Test for Breast Cancer Screening Mammography is sophisticated medical imaging that uses a low-dose x-ray device to view human breasts indoors. Mammography plays a vital role in the early detection and treatment of women with breast diseases. Breast Magnetic Resonance Imaging (MRI) or breast ultrasound, in addition to mammography, also helps detect breast cancer in women. Request a free Brochure copy of the report: https://www.renub.com/request-brochure-page.php?gturl=breast-cancer-screening-mammography-mri-and-ultrasound-market-and-forecast-worldwide-63-p.php Breast Cancer Screening Market

7. Breast Cancer Screening Market Countries – Total 23 Countries Market & Population for Breast Cancer Screening, Mammography Screening, MRI Screening & Ultrasound Screening has been studied in the report The study includes a comprehensive Breast cancer overview of Canada, France, Italy, Spain, Switzerland, Netherlands, Norway, India, Australia, Japan, Korea, Singapore, Thailand, Malaysia, Brazil, New Zealand, South Africa, United Arab Emirates and Saudi Arabia Breast Cancer, Mammography, Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population and Market. The report provides a complete analysis of the key Growth Drivers, Challenges, Market, Screened Population, and their projections for the upcoming years till 2026. Breast Cancer Screening Market

8. Breast Cancer Screening Market All the companies have been studied from two points •    Recent Developments •    Sales Analysis Company Analysis •    AstraZeneca •    Novartis•    Sanofi •    Pfizer•    Bayer AG Breast Cancer Screening Market & Population - By Screening Tests Covered in the Report •    Mammography •    Magnetic Resonance Imaging (MRI)•    Ultrasound Breast Cancer Screening Market

9. Breast Cancer Screening Market Forecast for Global Breast Cancer Screening Population Share (%) - By Screening Tests (2020-2026) Source: Renub Research Analysis Note: These are dummy figures; actual data given in the report Breast Cancer Screening Market

10. Breast Cancer Screening Market 23 Regions Covered in the Report: 1.    United States 2.    Canada 3.    United Kingdom 4.    France5.    Germany 6.    Italy7.    Spain 8.    Netherlands9.    Norway 10.    Switzerland11.    India 12.    China13.    Japan 14.    Korea15.    Singapore 16.    Thailand17.    Malaysia 18.    Brazil19.    Australia 20.    New Zealand21.    South Africa 22.    United Arab Emirates23.    Saudi Arabia Breast Cancer Screening Market

11. Breast Cancer Screening Market • Browse Related Report : • Molecular Diagnostics Market • Drug Abuse Testing Market • Contact Us • Tel: +1-678-302-0700 (US), • +91-120-421-9822 (INDIA) • Email: info@renub.com Breast Cancer Screening Market